Maria Sol Cruz

Director of CEDINOR
Centro Diabetologico del Norte (CEDINOR)

Presentation(s):

• PB1126 - Safety and efficacy of simoctocog alfa in patients with haemophilia A in routine clinical practice (GENA-99)

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM

• PB1149 - Pooled analysis of long-term efficacy and safety of simoctocog alfa in previously treated patients with haemophilia A

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM